Information  X 
Enter a valid email address

Morgan Stanley & Co. (48QN)

  Print   

Thursday 26 September, 2019

Morgan Stanley & Co.

Stabilisation Notice

RNS Number : 8203N
Morgan Stanley & Co. Int'l plc
26 September 2019
 

26 September 2019

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

PERMANENT TSB GROUP HOLDINGS P.L.C.

Post-stabilisation Notice

Further to the pre-stabilisation period announcement dated 19 September 2019, Morgan Stanley & Co. International plc (contact: Matteo Benedetto; telephone: +4420776773409) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

 

Issuer:

PERMANENT TSB GROUP HOLDINGS P.L.C.

Guarantor (if any):

N/A

Aggregate nominal amount:

EUR 300,000,000

Description:

EUR 300,000,000 2.125 per cent. Reset Notes due 2024

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

BNP Paribas

Goldman Sachs International

Offer price:

99.909 per cent.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration.  There has not been and will not be a public offer of the securities in the United States.

END.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
STALFMBTMBTTBIL

a d v e r t i s e m e n t